TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells

International Journal of Oncology

Volumn 44, Issue 2, 2014, Pages 573-582

  Sisinni, Lorenza ^a   Maddalena, Francesca ^a   Lettini, Giacomo ^a   Condelli, Valentina ^a   Matassa, Danilo Swann ^b   Esposito, Franca ^b   Landriscina, Matteo ^c  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Anthracyclins; Apoptosis; Drug resistance; Endoplasmic reticulum stress; TNF receptor associated protein 1

Indexed keywords

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BORONIC ACIDS; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; EIF-2 KINASE; ENDOPLASMIC RETICULUM STRESS; FEMALE; HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84894453220     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2199     Document Type: Article

References (40)

1. Walter P and Ron D: The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081-1086, 2011.
2. Schröder M and Kaufman RJ: The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789, 2005. (Pubitemid 40995523)
3. Ron D and Walter P: Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519-529, 2007. (Pubitemid 46985379)
4. Ellgaard L and Helenius A: Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4: 181-191, 2003. (Pubitemid 36288040)
5. Ron D: Translational control in the endoplasmic reticulum stress response. J Clin Invest 110: 1383-1388, 2002.
6. Tassone P, Tagliaferri P, Fulciniti MT, Di Martino MT and Venuta S: Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: experimental models and translational issues. Curr Pharm Des 13: 487-496, 2007. (Pubitemid 46477753)
7. Wilson TR, Johnston PG and Longley DB: Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer Drug Targets 9: 307-319, 2009.
8. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ and Lee AS: Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 278: 20915-20924, 2003. (Pubitemid 36806399)
9. Amoroso MR, Matassa DS, Laudiero G, et al: TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins. Cell Death Differ 19: 592-604, 2012.
10. Takemoto K, Miyata S, Takamura H, Katayama T and Tohyama M: Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum. Neurochem Int 58: 880-887, 2011.
11. Siegelin MD, Dohi T, Raskett CM, et al: Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest 121: 1349-1360, 2011.
12. Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ and Altieri DC: Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 131: 257-270, 2007. (Pubitemid 47576138)
13. Costantino E, Maddalena F, Calise S, et al: TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer Lett 279: 39-46, 2009.
14. Leav I, Plescia J, Goel HL, et al: Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am J Pathol 176: 393-340, 2009.
15. Fang W, Li X, Jiang Q, et al: Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 6: 32, 2008.
16. Landriscina M, Maddalena F, Laudiero G and Esposito F: Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 11: 2701-2716, 2009.
17. Landriscina M, Laudiero G, Maddalena F, et al: Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res 70: 6577-6586, 2010.
18. Maddalena F, Sisinni L, Lettini G, et al: Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1. Mol Oncol 7: 895-906, 2013.
19. Hande KR: Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim Biophys Acta 1400: 173-184, 1998.
20. Minotti G, Menna P, Salvatorelli E, Cairo G and Gianni L: Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56: 185-229, 2004. (Pubitemid 38720829)
21. Jiang CC, Mao ZG, Avery-Kiejda KA, Wade M, Hersey P and Zhang XD: Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. Carcinogenesis 30: 197-204, 2009.
22. Chae YC, Caino MC, Lisanti S, et al: Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. Cancer Cell 22: 331-344, 2012.
23. Scriven P, Coulson S, Haines R, Balasubramanian S, Cross S and Wyld L: Activation and clinical significance of the unfolded protein response in breast cancer. Br J Cancer 101: 1692-1698, 2009.
24. Tan SS, Ahmad I, Bennett HL, et al: GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer. J Pathol 223: 81-87, 2011.
25. Khasraw M, Bell R and Dang C: Epirubicin: is it like doxorubicin in breast cancer? A clinical review. Breast 21: 142-149, 2012.
26. Barone C, Landriscina M, Quirino M, et al: Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial. Br J Cancer 96: 21-28, 2007. (Pubitemid 46094634)
27. Landriscina M, Fabiano A, Altamura S, et al: Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. J Clin Endocrinol Metab 90: 5663-5671, 2005. (Pubitemid 41415473)
28. Maddalena F, Laudiero G, Piscazzi A, et al: Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis. Cancer Res 71: 7659-7669, 2011.
29. Feng R, Zhai WL, Yang HY, Jin H and Zhang QX: Induction of ER stress protects gastric cancer cells against apoptosis induced by cisplatin and doxorubicin through activation of p38 MAPK. Biochem Biophys Res Commun 406: 299-304, 2011.
30. Mhaidat NM, Thorne R, Zhang XD and Hersey P: Involvement of endoplasmic reticulum stress in Docetaxel-induced JNK-dependent apoptosis of human melanoma. Apoptosis 13: 1505-1512, 2008.
31. Harding HP, Zhang Y and Ron D: Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397: 271-274, 1999. (Pubitemid 29051178)
32. Harding HP, Novoa I, Zhang Y, et al: Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6: 1099-1108, 2000.
33. Farmaki E, Mkrtchian S, Papazian I, Papavassiliou AG and Kiaris H: ERp29 regulates response to doxorubicin by a PERK-mediated mechanism. Biochim Biophys Acta 1813: 1165-1171, 2011.
34. Matassa DS, Amoroso MR, Crudele V, et al: Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1. Cell Death Dis 4: e851, doi: 10.1038/cddis.2013.379, 2013.
35. Wang J, Yin Y, Hua H et al: Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response. J Cell Mol Med 13: 3888-3897, 2009.
36. Kang BH: TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors. BMB Rep 45: 1-6, 2012.
37. Neckers L, Kern A and Tsutsumi S: Hsp90 inhibitors disrupt mitochondrial homeostasis in cancer cells. Chem Biol 14: 1204-1206, 2007. (Pubitemid 350110540)
38. Xu W, Mimnaugh E, Rosser MF et al: Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J Biol Chem 276: 3702-3708, 2001.
39. Basso AD, Solit DB, Munster PN and Rosen N: Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene 21: 1159-1166, 2002. (Pubitemid 34185232)
40. Brouckaert O, Wildiers H, Floris G and Neven P: Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health 4: 511-520, 2012.